SCHEMBL188480

SCHEMBL188480

N=CN[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 7/20 0.55
NAALAD2 Q9Y3Q0 3/20 0.55
RIMKLA Q8IXN7 1/20 0.55
GGH Q92820 2/20 0.47
TET2 Q6N021 3/20 0.41
KDM4A O75164 2/20 0.41
KDM4C Q9H3R0 2/20 0.41
KDM2A Q9Y2K7 2/20 0.41
TET3 O43151 1/20 0.41
CYP1A2 P05177 2/20 0.40
GRM8 O00222 1/20 0.40
GRM6 O15303 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GSR P00390 1/20 0.40
GRIK1 P39086 1/20 0.40
GRM5 P41594 1/20 0.40
GRIA1 P42261 1/20 0.40
GRIA2 P42262 1/20 0.40
GRIA3 P42263 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL641942 1.00 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL29123177 1.00 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL2921881 0.84 KMT2A (0.45) FOLH1NAALAD2RIMKLA
SCHEMBL15935963 0.81 FOLH1 (0.57) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL702004 0.81 FOLH1 (0.57) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL702003 0.81 FOLH1 (0.57) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL5089988 0.79 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL28883926 0.79 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL5089992 0.79 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHTET2
SCHEMBL4406367 0.78 CA2 (0.41) FOLH1NAALAD2RIMKLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692783-A1 BIOMARKER AND SYSTEM FOR PREDICTING EVOLUTION INTO ACLF OR DEATH OF ACLF PATIENT, AND USES THEREOF Shanghai Ganning Medical and Technology Co., Ltd (CN) 2026-02-11 EP claimed
EP-4679087-A1 BIOMARKER AND USE THEREOF MEIJI CO., LTD (JP) 2026-01-14 EP claimed
CN-119269659-A Application of urine organic acid in health management 欧湧淳 2025-01-07 CN claimed
EP-4457514-A1 COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE Société des Produits Nestlé S.A. (CH) 2024-11-06 EP claimed
CN-118688333-A Marker related to allergic rhinitis and kit thereof 厦门市迈理奥科技有限公司 2024-09-24 CN claimed
WO-2024190663-A1 BIOMARKER AND USE THEREOF 株式会社明治 2024-09-19 WO claimed
CN-117214314-B Organic acid content detection box and detection method 深圳爱湾智造科技有限公司 2024-06-07 CN claimed
CN-117949571-A Application of liver cancer related urine marker in preparation of product for diagnosis/prognosis of liver cancer 江西省肿瘤医院(江西省第二人民医院、江西省癌症中心) 2024-04-30 CN claimed
US-20230405091-A1 METHODS OF MODULATING GASTROINTESTINAL METABOLITES DSM IP ASSETS B.V. (NL) 2023-12-21 US claimed
EP-4228424-A1 METHODS OF MODULATING GASTROINTESTINAL METABOLITES DSM IP Assets B.V. (NL) 2023-08-23 EP claimed
WO-2018049372-A1 HIV CLINICAL PLAN EXCISION BIOTHERAPEUTICS INC (US) 2018-03-15 WO claimed
WO-2017205460-A1 METABALOMICS AND VIRAL DIAGNOSTICS SUITE EXCISION BIOTHERAPEUTICS, INC. (US) 2017-11-30 WO claimed
WO-2017189528-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME Ecolab USA, Inc. (US) 2017-11-02 WO claimed
US-20170306504-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME CHAMPIONX LLC 2017-10-26 US claimed
US-20170199978-A1 USE OF AN EVIDENCE-BASED, TRANSLATIONAL ALGORITHM TO, INTER ALIA, ASSESS BIOMARKERS GENOVA DIAGNOSTICS, INC. 2017-07-13 US claimed
EP-3172564-A1 USE OF AN EVIDENCE-BASED, TRANSLATIONAL ALGORITHM TO, INTER ALIA, ASSESS BIOMARKERS Genova Diagnostics, Inc. (US) 2017-05-31 EP claimed
US-20170051323-A1 Method for Producing L-Amino Acids Using an Alkaliphilic Bacteria EVONIK DEGUSSA GMBH (DE) 2017-02-23 US claimed
WO-2016011434-A1 USE OF AN EVIDENCE-BASED, TRANSLATIONAL ALGORITHM TO, INTER ALIA, ASSESS BIOMARKERS LANDIS DARRYL (US) 2016-01-21 WO claimed
US-20120238030-A1 Methods and Systems for Multiplex Analysis of Biomolecules by Liquir Chromatography-Mass Spectrometry LABORATORY CORPORATION OF AMERICA HOLDINGS (US) 2012-09-20 US claimed
US-20080156068-A1 Treatment of Chromosomal Abnormalities in Fetuses Through A Comprehensive Metabolic Analysis of Amniotic Fluid BAGGOT PADDY JIM 2008-07-03 US claimed